{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:28:40Z","timestamp":1790378920744,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032645","name":"Hevolution Foundation","doi-asserted-by":"crossref","award":["HF-GRO-23-1199172-46"],"award-info":[{"award-number":["HF-GRO-23-1199172-46"]}],"id":[{"id":"10.13039\/100032645","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11914-025-00908-3","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T03:43:51Z","timestamp":1745379831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of Canonical and Non-Canonical Sphingolipids and their Metabolic Enzymes in Bone Health"],"prefix":"10.1007","volume":"23","author":[{"given":"Chiaki","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Akkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Movila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"12","key":"908_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/0022034510377791","volume":"89","author":"AL Boskey","year":"2010","unstructured":"Boskey AL, Coleman R. Aging and bone. J Dent Res. 2010;89(12):1333\u201348.","journal-title":"J Dent Res"},{"issue":"8","key":"908_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/s12276-020-0472-3","volume":"52","author":"JY Choi","year":"2020","unstructured":"Choi JY. Healthy bone tissue homeostasis. Exp Mol Med. 2020;52(8):1165.","journal-title":"Exp Mol Med"},{"key":"908_CR3","doi-asserted-by":"crossref","unstructured":"Su P et al. Mesenchymal stem cell migration during bone formation and bone diseases therapy. Int J Mol Sci, 2018. 19(8).","DOI":"10.3390\/ijms19082343"},{"key":"908_CR4","doi-asserted-by":"crossref","unstructured":"Kim JM et al. Osteoblast-Osteoclast communication and bone homeostasis. Cells, 2020. 9(9).","DOI":"10.3390\/cells9092073"},{"issue":"16","key":"908_CR5","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.7150\/ijms.61080","volume":"18","author":"N Yang","year":"2021","unstructured":"Yang N, Liu Y. The role of the immune microenvironment in bone regeneration. Int J Med Sci. 2021;18(16):3697\u2013707.","journal-title":"Int J Med Sci"},{"issue":"11","key":"908_CR6","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1002\/jor.25172","volume":"39","author":"AM Knox","year":"2021","unstructured":"Knox AM, et al. Methodology, selection, and integration of fracture healing assessments in mice. J Orthop Res. 2021;39(11):2295\u2013309.","journal-title":"J Orthop Res"},{"issue":"3","key":"908_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i3.40","volume":"22","author":"JP Bidwell","year":"2012","unstructured":"Bidwell JP, et al. Nmp4\/CIZ closes the parathyroid hormone anabolic window. Crit Rev Eukaryot Gene Expr. 2012;22(3):205\u201318.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.plipres.2015.06.002","volume":"59","author":"A During","year":"2015","unstructured":"During A, Penel G, Hardouin P. Understanding the local actions of lipids in bone physiology. Prog Lipid Res. 2015;59:126\u201346.","journal-title":"Prog Lipid Res"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2020.08.004","volume":"178","author":"A During","year":"2020","unstructured":"During A. Osteoporosis: A role for lipids. Biochimie. 2020;178:49\u201355.","journal-title":"Biochimie"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coph.2016.06.005","volume":"29","author":"V Chiurchiu","year":"2016","unstructured":"Chiurchiu V, Maccarrone M. Bioactive lipids as modulators of immunity, inflammation and emotions. Curr Opin Pharmacol. 2016;29:54\u201362.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"908_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"908_CR12","doi-asserted-by":"crossref","unstructured":"Seal A et al. Sphingolipid-Induced bone regulation and its emerging role in dysfunction due to disease and infection. Int J Mol Sci, 2024. 25(5).","DOI":"10.3390\/ijms25053024"},{"key":"908_CR13","doi-asserted-by":"crossref","unstructured":"Romero-Marquez JM et al. Molecular interactions between dietary lipids and bone tissue during aging. Int J Mol Sci, 2021. 22(12).","DOI":"10.3390\/ijms22126473"},{"issue":"18","key":"908_CR14","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/sj.emboj.7600798","volume":"24","author":"G van Meer","year":"2005","unstructured":"van Meer G. Cellular lipidomics. EMBO J. 2005;24(18):3159\u201365.","journal-title":"EMBO J"},{"issue":"29","key":"908_CR15","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","volume":"277","author":"AH Merrill Jr","year":"2002","unstructured":"Merrill AH Jr. De Novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 2002;277(29):25843\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"908_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19(3):175\u201391.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"908_CR17","doi-asserted-by":"publisher","first-page":"115838","DOI":"10.1016\/j.biopha.2023.115838","volume":"169","author":"X Xu","year":"2023","unstructured":"Xu X, et al. The role of SphK\/S1P\/S1PR signaling pathway in bone metabolism. Biomed Pharmacother. 2023;169:115838.","journal-title":"Biomed Pharmacother"},{"key":"908_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.phrs.2017.08.013","volume":"125Pt B","author":"Z Sartawi","year":"2017","unstructured":"Sartawi Z, et al. Sphingosine 1-phosphate (S1P) signalling: role in bone biology and potential therapeutic target for bone repair. Pharmacol Res. 2017;125Pt B:232\u201345.","journal-title":"Pharmacol Res"},{"issue":"2","key":"908_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbrc.2018.11.154","volume":"508","author":"J Yu","year":"2019","unstructured":"Yu J, et al. Ceramide kinase regulates the migration of bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2019;508(2):361\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"908_CR20","doi-asserted-by":"crossref","unstructured":"Duarte C et al. Elusive roles of the different ceramidases in human health, pathophysiology, and tissue regeneration. Cells, 2020. 9(6).","DOI":"10.3390\/cells9061379"},{"issue":"9","key":"908_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/jcmm.17722","volume":"27","author":"C Yamada","year":"2023","unstructured":"Yamada C, et al. Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells. J Cell Mol Med. 2023;27(9):1290\u20135.","journal-title":"J Cell Mol Med"},{"key":"908_CR22","doi-asserted-by":"crossref","unstructured":"Bartke N, Hannun YA. Bioactive sphingolipids: metabolism and function. J Lipid Res, 2009. 50 Suppl(Suppl): pp. S91\u20136.","DOI":"10.1194\/jlr.R800080-JLR200"},{"issue":"2","key":"908_CR23","doi-asserted-by":"publisher","first-page":"e16771","DOI":"10.1371\/journal.pone.0016771","volume":"6","author":"FC Nichols","year":"2011","unstructured":"Nichols FC, et al. Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues. PLoS ONE. 2011;6(2):e16771.","journal-title":"PLoS ONE"},{"key":"908_CR24","doi-asserted-by":"publisher","first-page":"752540","DOI":"10.3389\/fcell.2021.752540","volume":"9","author":"T Qi","year":"2021","unstructured":"Qi T, Li L, Weidong T. The role of sphingolipid metabolism in bone remodeling. Front Cell Dev Biol. 2021;9:752540.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"908_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.bbalip.2017.01.008","volume":"1862","author":"H Kanzaki","year":"2017","unstructured":"Kanzaki H, et al. Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(5):452\u201362.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"908_CR26","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1128\/IAI.00225-10","volume":"78","author":"YH Wang","year":"2010","unstructured":"Wang YH, et al. Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function. Infect Immun. 2010;78(9):3726\u201335.","journal-title":"Infect Immun"},{"issue":"10","key":"908_CR27","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1111\/jcmm.17299","volume":"26","author":"C Duarte","year":"2022","unstructured":"Duarte C, et al. Crosstalk between dihydroceramides produced by Porphyromonas gingivalis and host lysosomal cathepsin B in the promotion of osteoclastogenesis. J Cell Mol Med. 2022;26(10):2841\u201351.","journal-title":"J Cell Mol Med"},{"key":"908_CR28","doi-asserted-by":"crossref","unstructured":"Quinville BM et al. A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis. Int J Mol Sci, 2021. 22(11).","DOI":"10.3390\/ijms22115793"},{"issue":"4","key":"908_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ymgme.2018.06.007","volume":"124","author":"MC Reed","year":"2018","unstructured":"Reed MC, et al. Impact of sphingolipids on osteoblast and osteoclast activity in gaucher disease. Mol Genet Metab. 2018;124(4):278\u201386.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"908_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41398-020-0819-5","volume":"10","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. Long-term use of Fluoxetine accelerates bone loss through the disruption of sphingolipids metabolism in bone marrow adipose tissue. Transl Psychiatry. 2020;10(1):138.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"908_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jbmr.2150","volume":"29","author":"Z Drosatos-Tampakaki","year":"2014","unstructured":"Drosatos-Tampakaki Z, et al. Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J Bone Min Res. 2014;29(5):1183\u201395.","journal-title":"J Bone Min Res"},{"issue":"1","key":"908_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bbrc.2014.06.063","volume":"450","author":"LC Yeh","year":"2014","unstructured":"Yeh LC, et al. Palmitate attenuates osteoblast differentiation of fetal rat calvarial cells. Biochem Biophys Res Commun. 2014;450(1):777\u201381.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"908_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","volume":"188","author":"JB Moon","year":"2012","unstructured":"Moon JB, et al. Akt induces osteoclast differentiation through regulating the GSK3beta\/NFATc1 signaling cascade. J Immunol. 2012;188(1):163\u20139.","journal-title":"J Immunol"},{"issue":"26","key":"908_CR34","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1074\/jbc.273.26.16568","volume":"273","author":"H Zhou","year":"1998","unstructured":"Zhou H, et al. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem. 1998;273(26):16568\u201375.","journal-title":"J Biol Chem"},{"issue":"696","key":"908_CR35","doi-asserted-by":"publisher","first-page":"eade6509","DOI":"10.1126\/scitranslmed.ade6509","volume":"15","author":"TI Lima","year":"2023","unstructured":"Lima TI, et al. Inhibiting de Novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging. Sci Transl Med. 2023;15(696):eade6509.","journal-title":"Sci Transl Med"},{"key":"908_CR36","doi-asserted-by":"publisher","first-page":"1077058","DOI":"10.3389\/fendo.2023.1077058","volume":"14","author":"C Yan","year":"2023","unstructured":"Yan C, et al. Mitochondrial quality control and its role in osteoporosis. Front Endocrinol (Lausanne). 2023;14:1077058.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"908_CR37","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, et al. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 2021;33(7):1293\u2013306.","journal-title":"Cell Metab"},{"key":"908_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbior.2018.08.002","volume":"70","author":"D Davis","year":"2018","unstructured":"Davis D, Kannan M, Wattenberg B. Orm\/ORMDL proteins: gate guardians and master regulators. Adv Biol Regul. 2018;70:3\u201318.","journal-title":"Adv Biol Regul"},{"issue":"9","key":"908_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.3934","volume":"21","author":"A Cantalupo","year":"2015","unstructured":"Cantalupo A, et al. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure. Nat Med. 2015;21(9):1028\u201337.","journal-title":"Nat Med"},{"issue":"35","key":"908_CR40","doi-asserted-by":"publisher","first-page":"25001","DOI":"10.1074\/jbc.R600010200","volume":"281","author":"Y Pewzner-Jung","year":"2006","unstructured":"Pewzner-Jung Y, Ben-Dor S, Futerman AH. When do lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem. 2006;281(35):25001\u20135.","journal-title":"J Biol Chem"},{"key":"908_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3389\/fendo.2020.00483","volume":"11","author":"S Raichur","year":"2020","unstructured":"Raichur S. Ceramide synthases are attractive drug targets for treating metabolic diseases. Front Endocrinol (Lausanne). 2020;11:483.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"908_CR42","doi-asserted-by":"crossref","unstructured":"Wohlwend M et al. Inhibition of CERS1 in skeletal muscle exacerbates age-related muscle dysfunction. Elife, 2024. 12.","DOI":"10.7554\/eLife.90522"},{"issue":"1","key":"908_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","volume":"26","author":"SM Turpin-Nolan","year":"2019","unstructured":"Turpin-Nolan SM, et al. CerS1-Derived C(18:0) ceramide in skeletal muscle promotes Obesity-Induced insulin resistance. Cell Rep. 2019;26(1):1\u2013e107.","journal-title":"Cell Rep"},{"issue":"6451","key":"908_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.aav3722","volume":"365","author":"B Chaurasia","year":"2019","unstructured":"Chaurasia B, et al. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science. 2019;365(6451):386\u201392.","journal-title":"Science"},{"issue":"1\u20133","key":"908_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-5793(04)00274-1","volume":"563","author":"Y Mizutani","year":"2004","unstructured":"Mizutani Y, Kihara A, Igarashi Y. Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation. FEBS Lett. 2004;563(1\u20133):93\u20137.","journal-title":"FEBS Lett"},{"issue":"3","key":"908_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","volume":"5","author":"WL Holland","year":"2007","unstructured":"Holland WL, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 2007;5(3):167\u201379.","journal-title":"Cell Metab"},{"issue":"11","key":"908_CR47","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1128\/MCB.00226-13","volume":"33","author":"MM Siddique","year":"2013","unstructured":"Siddique MM, et al. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Mol Cell Biol. 2013;33(11):2353\u201369.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"908_CR48","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1074\/jbc.AC119.011883","volume":"295","author":"G Karsai","year":"2020","unstructured":"Karsai G, et al. FADS3 is a Delta14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome. J Biol Chem. 2020;295(7):1889\u201397.","journal-title":"J Biol Chem"},{"issue":"3","key":"908_CR49","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1529\/biophysj.104.044529","volume":"87","author":"HL Brockman","year":"2004","unstructured":"Brockman HL, et al. The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys J. 2004;87(3):1722\u201331.","journal-title":"Biophys J"},{"issue":"25","key":"908_CR50","doi-asserted-by":"publisher","first-page":"15371","DOI":"10.1074\/jbc.R115.653204","volume":"290","author":"MM Siddique","year":"2015","unstructured":"Siddique MM, et al. Dihydroceramides: from bit players to lead actors. J Biol Chem. 2015;290(25):15371\u20139.","journal-title":"J Biol Chem"},{"issue":"8","key":"908_CR51","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1074\/jbc.M808798200","volume":"284","author":"NC Zitomer","year":"2009","unstructured":"Zitomer NC, et al. Ceramide synthase Inhibition by Fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J Biol Chem. 2009;284(8):4786\u201395.","journal-title":"J Biol Chem"},{"issue":"7","key":"908_CR52","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1194\/jlr.M067033","volume":"57","author":"R Steiner","year":"2016","unstructured":"Steiner R, et al. Elucidating the chemical structure of native 1-deoxysphingosine. J Lipid Res. 2016;57(7):1194\u2013203.","journal-title":"J Lipid Res"},{"key":"908_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1476-511X-9-84","volume":"9","author":"M Bertea","year":"2010","unstructured":"Bertea M, et al. Deoxysphingoid bases as plasma markers in diabetes mellitus. Lipids Health Dis. 2010;9:84.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"908_CR54","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1194\/jlr.R800012-JLR200","volume":"49","author":"ST Pruett","year":"2008","unstructured":"Pruett ST, et al. Biodiversity of sphingoid bases (sphingosines) and related amino alcohols. J Lipid Res. 2008;49(8):1621\u201339.","journal-title":"J Lipid Res"},{"issue":"23","key":"908_CR55","doi-asserted-by":"publisher","first-page":"14595","DOI":"10.1074\/jbc.M114.603860","volume":"290","author":"K Esaki","year":"2015","unstructured":"Esaki K, et al. L-Serine deficiency elicits intracellular accumulation of cytotoxic deoxysphingolipids and lipid body formation. J Biol Chem. 2015;290(23):14595\u2013609.","journal-title":"J Biol Chem"},{"issue":"2","key":"908_CR56","doi-asserted-by":"publisher","first-page":"e21284","DOI":"10.1096\/fj.202001814RR","volume":"35","author":"JP Truman","year":"2021","unstructured":"Truman JP, et al. Sphingosine kinase 1 downregulation is required for adaptation to Serine deprivation. FASEB J. 2021;35(2):e21284.","journal-title":"FASEB J"},{"issue":"2","key":"908_CR57","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10495-006-0573-z","volume":"12","author":"M Salcedo","year":"2007","unstructured":"Salcedo M, et al. The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway. Apoptosis. 2007;12(2):395\u2013409.","journal-title":"Apoptosis"},{"issue":"8","key":"908_CR58","doi-asserted-by":"publisher","first-page":"183628","DOI":"10.1016\/j.bbamem.2021.183628","volume":"1863","author":"TCB Santos","year":"2021","unstructured":"Santos TCB, et al. The long chain base unsaturation has a stronger impact on 1-deoxy(methyl)-sphingolipids biophysical properties than the structure of its C1 functional group. Biochim Biophys Acta Biomembr. 2021;1863(8):183628.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"908_CR59","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1073\/pnas.0709191105","volume":"105","author":"N Kudo","year":"2008","unstructured":"Kudo N, et al. Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A. 2008;105(2):488\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"908_CR60","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db17-0901","volume":"67","author":"CL Bandet","year":"2018","unstructured":"Bandet CL, et al. Ceramide transporter CERT is involved in muscle insulin signaling defects under lipotoxic conditions. Diabetes. 2018;67(7):1258\u201371.","journal-title":"Diabetes"},{"issue":"1","key":"908_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.plipres.2010.10.003","volume":"50","author":"GA Patwardhan","year":"2011","unstructured":"Patwardhan GA, Liu YY. Sphingolipids and expression regulation of genes in cancer. Prog Lipid Res. 2011;50(1):104\u201314.","journal-title":"Prog Lipid Res"},{"issue":"42","key":"908_CR62","doi-asserted-by":"publisher","first-page":"25356","DOI":"10.1074\/jbc.M115.658658","volume":"290","author":"MJ Hernandez-Corbacho","year":"2015","unstructured":"Hernandez-Corbacho MJ, et al. Tumor necrosis Factor-alpha (TNFalpha)-induced ceramide generation via ceramide synthases regulates loss of focal adhesion kinase (FAK) and programmed cell death. J Biol Chem. 2015;290(42):25356\u201373.","journal-title":"J Biol Chem"},{"issue":"21","key":"908_CR63","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.18632\/aging.102389","volume":"11","author":"BJ Kim","year":"2019","unstructured":"Kim BJ, et al. Elevated ceramides 18:0 and 24:1 with aging are associated with hip fracture risk through increased bone resorption. Aging. 2019;11(21):9388\u2013404.","journal-title":"Aging"},{"issue":"1","key":"908_CR64","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1038\/s41598-018-34574-6","volume":"8","author":"H Zhao","year":"2018","unstructured":"Zhao H, et al. Integrative bone Metabolomics-Lipidomics strategy for pathological mechanism of postmenopausal osteoporosis mouse model. Sci Rep. 2018;8(1):16456.","journal-title":"Sci Rep"},{"issue":"2","key":"908_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/JOE-10-0068","volume":"206","author":"PA Hill","year":"2010","unstructured":"Hill PA, Tumber A. Ceramide-induced cell death\/survival in murine osteoblasts. J Endocrinol. 2010;206(2):225\u201333.","journal-title":"J Endocrinol"},{"issue":"9","key":"908_CR66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","volume":"1781","author":"C Mao","year":"2008","unstructured":"Mao C, Obeid LM. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta. 2008;1781(9):424\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"908_CR67","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.cellsig.2020.109860","volume":"78","author":"R Xu","year":"2021","unstructured":"Xu R, Boasiako PA, Mao C. Alkaline ceramidase family: the first two decades. Cell Signal. 2021;78:109860.","journal-title":"Cell Signal"},{"key":"908_CR68","doi-asserted-by":"crossref","unstructured":"Parveen F et al. Role of ceramidases in sphingolipid metabolism and human diseases. Cells, 2019. 8(12).","DOI":"10.3390\/cells8121573"},{"issue":"3","key":"908_CR69","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1006\/bbrc.2000.3370","volume":"275","author":"E Romiti","year":"2000","unstructured":"Romiti E, et al. Neutral\/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem Biophys Res Commun. 2000;275(3):746\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"908_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1546-0096-5-15","volume":"5","author":"K Ehlert","year":"2007","unstructured":"Ehlert K, et al. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J. 2007;5:15.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"908_CR71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13023-018-0845-z","volume":"13","author":"FPS Yu","year":"2018","unstructured":"Yu FPS, et al. Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet J Rare Dis. 2018;13(1):121.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"908_CR72","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.bbrc.2017.12.137","volume":"495","author":"MM Azuma","year":"2018","unstructured":"Azuma MM, et al. Endogenous acid ceramidase protects epithelial cells from Porphyromonas gingivalis-induced inflammation in vitro. Biochem Biophys Res Commun. 2018;495(4):2383\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"908_CR73","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.stemcr.2017.09.015","volume":"9","author":"CL Lin","year":"2017","unstructured":"Lin CL, et al. Alkaline ceramidase 1 protects mice from premature hair loss by maintaining the homeostasis of hair follicle stem cells. Stem Cell Rep. 2017;9(5):1488\u2013500.","journal-title":"Stem Cell Rep"},{"issue":"11","key":"908_CR74","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1074\/jbc.M109.063586","volume":"285","author":"W Hu","year":"2010","unstructured":"Hu W, et al. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis. J Biol Chem. 2010;285(11):7964\u201376.","journal-title":"J Biol Chem"},{"issue":"1","key":"908_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, et al. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22(1):50\u201360.","journal-title":"Trends Cell Biol"},{"key":"908_CR76","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fendo.2020.00491","volume":"11","author":"S Tan-Chen","year":"2020","unstructured":"Tan-Chen S, et al. Sphingolipid metabolism and signaling in skeletal muscle: from physiology to physiopathology. Front Endocrinol (Lausanne). 2020;11:491.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"24","key":"908_CR77","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1038\/sj.emboj.7601430","volume":"25","author":"J Ryu","year":"2006","unstructured":"Ryu J, et al. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J. 2006;25(24):5840\u201351.","journal-title":"EMBO J"},{"key":"908_CR78","doi-asserted-by":"crossref","unstructured":"Walker JM et al. An unanticipated role for sphingosine Kinase-2 in bone and in the anabolic effect of parathyroid hormone. Endocrinology, 2021. 162(5).","DOI":"10.1210\/endocr\/bqab042"},{"key":"908_CR79","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2017.07.002","volume":"103","author":"C Bougault","year":"2017","unstructured":"Bougault C, et al. Involvement of sphingosine kinase\/sphingosine 1-phosphate metabolic pathway in spondyloarthritis. Bone. 2017;103:150\u20138.","journal-title":"Bone"},{"issue":"7","key":"908_CR80","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/14728222.2017.1332180","volume":"21","author":"A Meshcheryakova","year":"2017","unstructured":"Meshcheryakova A, Mechtcheriakova D, Pietschmann P. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential. Expert Opin Ther Targets. 2017;21(7):725\u201337.","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"908_CR81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jbmr\/zjae006","volume":"39","author":"A Wille","year":"2024","unstructured":"Wille A, et al. Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner. J Bone Min Res. 2024;39(3):357\u201372.","journal-title":"J Bone Min Res"},{"issue":"1","key":"908_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41368-022-00173-5","volume":"14","author":"B Choi","year":"2022","unstructured":"Choi B, et al. Sphingosine-1-phosphate hinders the osteogenic differentiation of dental pulp stem cells in association with AKT signaling pathways. Int J Oral Sci. 2022;14(1):21.","journal-title":"Int J Oral Sci"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-025-00908-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00908-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:04:39Z","timestamp":1768471479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-025-00908-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s11914-025-00908-3","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"21 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"21"}}